New COPD treatment approved for use in Europe

A new treatment for COPD has been approved for use in a number of European countries. Spiolto Respimat (tiotropium olodaterol) has been approved for use in Croatia, United Kingdom, Slovakia, Denmark, Norway, Ireland, Austria, Romania and Spain. The once-daily maintenance treatment relieves symptoms in adult patients with chronic obstructive pulmonary disease (COPD). Approvals of the treatment in other European countries are expected to follow in the coming months. It has been proven to provide significant improvements in lung function, COPD symptoms, quality of life and rescue medication use over Spiriva. It has also been proven to more than doubles lung